inducement

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on June 16, 2025, it granted stock options to purchase an aggregate of 37,200 shares of common stock to two new

SOUTH SAN FRANCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on June 15, 2025 it granted stock options to purchase an aggregate of 83,583 shares of common stock and 56,334 restricted stock units (RSUs) that will be settled in shares of common stock upon vesting to 11 employees, whose employment commenced in May and June, 2025, as a material inducement to their employment.

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on June 13, 2025, the company granted restricted stock units (RSUs) with respect to 10,290 shares of the company’s common stock to five newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made as a material inducement t

DUBLIN, June 16, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non-statutory options to two new employees to purchase 9,600 ordinary shares under Avadel’s 2021 Inducement Plan. In addition, effective as of May 13, 2025, the Compensation Committee of Avadel’s Board of Directors approved a grant of non-statutory options to Susan Rodriguez, Avadel’s newly appointed Chief Operating Officer, to purchase 300,000 ordinary shares under Avadel’s 2021 Inducement Plan.

HILLSBORO, Ore.--(BUSINESS WIRE)---- $LSCC #FPGA--Lattice Semiconductor Corporation (Nasdaq: LSCC), the low power programmable leader, today announced that on June 10, 2025 (“Grant Date”), Lattice Semiconductor granted a total of 88,848 restricted stock units (“RSUs”) to 29 new non-executive employees who began their employment with Lattice Semiconductor during May 2025. These inducement grants were granted pursuant to Lattice Semiconductor’s 2025 Inducement Equity Incentive Plan (“Inducement Plan”). The RSUs

SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on June 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants to 15 new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 81,100 shares of its common stock. These inducement RSUs are subject to the terms of Travere’s 2018 Equity Incentive Plan (“2018 Plan”) but were granted outside of the 2018 Plan and were granted as in

ORANGE COUNTY, Calif.--(BUSINESS WIRE)--Virgin Galactic Holdings, Inc. (NYSE: SPCE) (“Virgin Galactic”) announced that the Compensation Committee of Virgin Galactic’s Board of Directors approved the grant of a time-based inducement restricted stock unit award of 30,096 shares of Virgin Galactic common stock to a new non-executive employee, effective June 15, 2025. The award was granted under Virgin Galactic’s Amended and Restated 2023 Employment Inducement Incentive Award Plan, which provides f